NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-217-2011-1-DE-14 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof DE EP 13712655.3 Issued
NCI E-217-2011-1-FR-15 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof FR EP 13712655.3 Issued
NCI E-217-2011-1-EP-07 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof EP National Stage 13712655.3 Issued
NCI E-217-2011-1-GB-16 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof GB EP 13712655.3 Issued
NCI E-217-2011-1-AU-03 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof AU National Stage 2013240301 Issued
NCI E-019-2012-0-DE-06 Soluble Engineered Monomeric FC DE EP 13713301.3 Issued
NCI E-019-2012-0-FR-07 Soluble Engineered Monomeric FC FR EP 13713301.3 Issued
NCI E-019-2012-0-GB-08 Soluble Engineered Monomeric FC GB EP 13713301.3 Issued
NCI E-019-2012-0-EP-03 Soluble Engineered Monomeric FC EP National Stage 13713301.3 Issued
NCI E-217-2011-1-JP-09 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof JP National Stage 2015-503310 Issued
NCI E-289-2011-0-US-03 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF US National Stage 13/803,757 9533031 Issued PDF
NCI E-056-2011-0-US-03 Yeast-Brachyury Immunotherapeutic Compositions US National Stage 13/803,719 9198941 Issued PDF
NCI E-217-2011-1-PCT-02 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof PCT PCT PCT/US2013/031624 Expired
NCI E-019-2012-0-PCT-02 Soluble Engineered Monomeric FC PCT PCT PCT/US13/31593 Expired
NIAID E-039-1999-0-US-14 A Novel Chimeric Protein for Prevention and Treatment of HIV Infection US DIV 13/831,464 Abandoned
NCI E-217-2011-1-BR-04 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof BR National Stage BR112014023642-9 Abandoned
NCI E-217-2011-1-IN-08 Novel Interferon-LambdA4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof IN National Stage 8806/DELNP/2014 Abandoned
NHGRI E-056-2013-0-US-01 Biomarker For Hyposialylation Disorders US 61/785,094 Abandoned
NHLBI E-027-2013-0-US-01 Devices And Methods for Treating Functional Triscupid Valve Regurgitation US 61/785,652 Abandoned
NHGRI E-060-2013-0-US-01 Compositions and Methods for Predicting Age of Onset of A Lysosomal Storage Disease or a Disease Associated with a Lysosomal Defect US 61/781,807 Abandoned
NIAID E-112-2013-0-US-01 Use of Arsenical Compounds to Treat Inflammatory Diseases US 61/784,138 Abandoned
NCATS E-299-2012-0-US-01 Pyrazolo[1,5-a]pyrimidine Derivatives As Selective Inhibitors Of ALK Kinases For Inhibition Of The Bone Morphogenetic Proteins (BMP) Signaling Pathway US 61/783,695 Abandoned
NIDCD E-247-2011-0-US-01 SYSTEMS AND METHODS FOR BLEACHING/BLINKING ASSISTED LOCALIZATION MICROSCOPY FOR SUPERRESOLUTION IMAGING USING STANDARD FLUORESCENT MOLECULES US 61/784,266 Abandoned
NIMH E-053-2013-0-US-01 A Diagnostic Kit For Assessing Exposure Or Infection By The Koala Family Of Gammaretroviruses US 61/784,763 Abandoned
NCI E-094-2013-0-US-01 Peptide and Peptide Mimetic Binding Antagonists of Polo-like Kinase 1 Polo Box Domain and Methods of Use US 61/784,971 Abandoned
NIAAA E-316-2013-0-US-01 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate US 61/783,167 Abandoned
NCI E-055-2011-0-IT-11 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE IT EP 13773456.2 Issued
NCI E-055-2011-0-NL-12 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE NL EP 13773456.2 Issued
NCI E-055-2011-0-DE-07 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE DE EP 13773456.2 Issued
NCI E-055-2011-0-FR-09 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE FR EP 13773456.2 Issued
NCI E-055-2011-0-CH-06 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE CH EP 13773456.2 Issued
NCI E-055-2011-0-ES-08 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE ES EP 13773456.2 Issued
NCI E-055-2011-0-GB-10 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE GB EP 13773456.2 Issued
NIAID E-135-2010-0-GB-13 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production GB EP 13712641.3 Issued
NIAID E-135-2010-0-CH-10 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production CH EP 13712641.3 Issued
NIAID E-135-2010-0-IT-15 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IT EP 13712641.3 Issued
NIAID E-135-2010-0-IE-14 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IE EP 13712641.3 Issued
NIAID E-135-2010-0-FR-12 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production FR EP 13712641.3 Issued
NIAID E-135-2010-0-DE-11 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production DE EP 13712641.3 Issued
NIAID E-135-2010-0-BE-09 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production BE EP 13712641.3 Issued
NIAID E-135-2010-0-NL-16 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production NL EP 13712641.3 Issued
NIAID E-135-2010-0-EP-04 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production EP National Stage 13712641.3 Issued
NIDDK E-091-2006-1-US-02 A3 Adenosine Receptor Allosteric Modulators US CON 13/800,560 9326978 Issued PDF
NIDCR E-257-2012-0-US-02 Methods Of Preventing The Development Of Mucositis And Related Disorders US ORD 13/798,863 9278090 Issued PDF
NIAID E-135-2010-0-PCT-02 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION PCT PCT PCT/US2013/030836 Expired
NIAID E-081-2013-0-US-01 Prefusion RSV F Proteins and Their Use US 61/780,910 Abandoned
NCI E-111-2013-0-US-01 TetraHydroxamate Chelators of Zirconium89 For Use In Diagnostic Applications US 61/779,016 Abandoned
NCI E-296-2011-0-US-01 Methods For Modulating Chemotherapeutic Cytotoxicity US 61/779,587 Abandoned
NLM E-107-2010-2-US-03 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 13/795,739 9447452 Issued PDF
NCI E-135-2012-0-PCT-02 DNA Methylation Analysis For The Diagnosis, Prognosis, and Treatment Of Adrenal Neoplasms PCT PCT PCT/US2013/030347 Expired